Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HLCS | P50747 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 9/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12653853 | 1.00 | FUCA1 (0.42) | FUCA1ALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL12991554 | 0.98 | ALDH1A1 (0.41) | FUCA1ALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL17021214 | 0.92 | ALDH1A1 (0.47) | FUCA1ALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL19303363 | 0.76 | ALDH1A1 (0.44) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL5811056 | 0.76 | GBA1 (0.44) | FUCA1GBA1GAA | |
| SCHEMBL6561453 | 0.74 | ABL1 (0.65) | FUCA1ALDH1A1HPGDL3MBTL1HLCS | |
| SCHEMBL30980779 | 0.74 | ABL1 (0.65) | FUCA1ALDH1A1HPGDL3MBTL1HLCS | |
| SCHEMBL5442521 | 0.74 | ALDH1A1 (0.45) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL10005090 | 0.74 | ALDH1A1 (0.45) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL14141054 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130004453-A1 | NYLON-3 CO-POLYMERS AND SYNTHETIC LUNG SURFACTANT COMPOSITIONS CONTAINING SAME | NATIONAL SCIENCE FOUNDATION | 2013-01-03 | — | — | US | disclosed |
| US-20070087404-A1 | Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130004453-A1 | NYLON-3 CO-POLYMERS AND SYNTHETIC LUNG SURFACTANT COMPOSITIONS CONTAINING SAME | SURF4, PLIN3, CLTB | FUCA1 4697/4885ALDH1A1 4859/4885KDM4E 4706/4885 |
| US-20070087404-A1 | Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same | TMSB10, TMSB4X, PTMA | FUCA1 4246/4885ALDH1A1 4840/4885KDM4E 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.